Shintaro Hirata

Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High‐Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti–Melanoma Differentiation–Associated Gene 5–Positive Dermatomyositis

Hideaki Tsuji, Ran Nakashima, Yuji Hosono et al. · Arthritis & Rheumatology · 2019 · 361 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression.

Yoshinobu Ohsaki, Satoshi Tanno, Yasuko Fujita et al. · Oncology Reports · 2000 · 255 citations

Medicine, Cancer Biology, Oncology +14

Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study

Yoshiya Tanaka, Shintaro Hirata, Satoshi Kubo et al. · Annals of the Rheumatic Diseases · 2013 · 199 citations · Full text

Veterinary Medicine, Immunology, Internal Medicine +17

2019 Diagnostic criteria for mixed connective tissue disease (MCTD): From the Japan research committee of the ministry of health, labor, and welfare for systemic autoimmune diseases

Yoshiya Tanaka, Masataka Kuwana, Takao Fujii et al. · Modern Rheumatology · 2020 · 134 citations · Full text

Medicine, Dermatology, Immunology +16

Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study)

Yuko Kaneko, Tatsuya Atsumi, Yoshiya Tanaka et al. · Annals of the Rheumatic Diseases · 2016 · 113 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15